News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Invests $150 Million In R&D at Jamia Millia Islamic University


4/23/2012 8:01:34 AM

MSD India, a wholly owned subsidiary of Merck & Co. Inc., US which invested $150 million in setting up a research & development (R&D) centre at the Jamia Millia Islamic University is now working to commission the same at the earliest. The facility will focus on vaccine research and drugs for new diseases.The research centre is a not- for - profit initiative by the global pharma major. “Considerable work is in progress to ensure that we are able to open the centre at the earliest and it is difficult for us to give the exact time of commencement of research. The company invested in the R&D in India going by the promising prospects to research on the vaccines and make available a slew of preventive solutions to control some of the dreaded diseases,” K G Ananthakrishnan, managing director MSD India said.

Read at PharmaBiz


comments powered by Disqus
PharmaBiz
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES